Interpretation of the Mantoux Test

Procedure and Administration of the Mantoux Test

The Mantoux test is a crucial screening tool for tuberculosis infection. It involves an intradermal injection and subsequent measurement of skin induration to determine TB exposure.

6/7/20255 min read27 views
loved it
normalintermediateRespiratory Medicine
Mantoux Test: Procedure, Administration, and Interpretation

Interpretation of the Mantoux Test

Procedure and Administration of the Mantoux Test

The Mantoux test, also known as the tuberculin skin test (TST), is a diagnostic tool used to identify latent tuberculosis (TB) infection. This test involves the intradermal injection of purified protein derivative (PPD) tuberculin, followed by measuring the induration after 48 to 72 hours.

Procedure

  • Preparation: The skin is cleansed with alcohol, usually on the volar aspect of the forearm.
  • Injection: 0.1 mL of PPD tuberculin is injected intradermally using a 27-gauge needle, forming a visible wheal of approximately 6-10 mm.
  • Assessment: Induration is measured at 48-72 hours using the ballpoint method.

Interpretation of Results

  • Positive (>5 mm in high-risk groups): Indicates probable TB infection and requires further evaluation.
  • Negative (<5 mm): Usually suggests no infection, though false negatives may occur in immunocompromised individuals.
  • Intermediate (5-10 mm): Requires further clinical correlation, particularly in patients with TB risk factors.

Limitations and Considerations

False-positive and false-negative results can occur due to BCG vaccination, improper administration, or immunosuppression. Additional diagnostic tests, such as interferon-gamma release assays (IGRAs), may be required for confirmation.

Tags

#Mantoux test#tuberculin skin test#TB diagnosis#PPD tuberculin#respiratory medicine

0 people loved it

Recommended Reads

Explore related articles that might interest you

Pharmacological Management of Cough: Antitussives, Expectorants, and Mucolytics
14
11%

Pharmacological Management of Cough: Antitussives, Expectorants, and Mucolytics

Read more →
14
Epidemiology, risk factors, and progression of obstructive airway diseases
5
11%

Epidemiology, risk factors, and progression of obstructive airway diseases

Read more →
5
Proper Use of Inhalers
50
11%

Proper Use of Inhalers

Read more →
50
Types of Samples for Demonstrating Mycobacterium tuberculosis
35
11%

Types of Samples for Demonstrating Mycobacterium tuberculosis

Read more →
35
Effective communication of diagnosis, treatment, and follow-up plan in respiratory medicine
20
11%

Effective communication of diagnosis, treatment, and follow-up plan in respiratory medicine

Read more →
20
Principles and Applications of Oxygen Therapy
21
11%

Principles and Applications of Oxygen Therapy

Read more →
21
Therapeutic plan for respiratory conditions, including the use of bronchodilators and inhaled corticosteroids
31
11%

Therapeutic plan for respiratory conditions, including the use of bronchodilators and inhaled corticosteroids

Read more →
31
© 2025 MedGloss. All rights reserved.